Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine

NCT02645032 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Typhoid

Interventions

BIOLOGICAL: Vi-DT
BIOLOGICAL: Typhim Vi®
BIOLOGICAL: VAXIGRIP®

Sponsor

International Vaccine Institute

Collaborators

[object Object]